Clinical trial for identifying the safety of the Ivermectin bath method.

Not Applicable

• Conditions: scabies

• Registration Number: JPRN-UMIN000008994
• Lead Sponsor: aboratory of medical safety management, Tokyo University of Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-27
• Study Completion: 2016-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient diagnosed with a skin disorder and thus has skin barrier problem 2) One who has had the experience of the following; - Hepatic disease - The disease considered to affect the test results by doctor in attendance. - The disease considered that use of Ivermectin results detrimental to the patient. 3) one with excessive consumption of caffeine contained coffee or drink (>8 cups / day) 4) abuser of medication or alcohol 5) The addict of an illegal drug 6) One who has contributed 200mL blood within 4 weeks before the trial, or male contributed 400mL blood within 12 weeks and female contributed 400mL blood within 16 weeks 7) One who participated in other clinical trials with the use of study medication within 4 weeks before the trial 8) One who has an anamnesis of hypersensitivity for the ingredients contained in Stromectol Tablets or in the baby bath powder (Pigeon, Inc.) 9) Pregnant female or lactating woman or child under 15kg weight 10) One whom the doctor considered to be unsuitable for this clinical trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified